SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-19-000147
Filing Date
2019-11-06
Accepted
2019-11-06 08:30:16
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph09301910q.htm 10-Q 914801
2 EXHIBIT 31.1 blph09301910qexhibit311.htm EX-31.1 9911
3 EXHIBIT 31.2 blph09301910qexhibit312.htm EX-31.2 9900
4 EXHIBIT 32 blph09301910qexhibit32.htm EX-32 10905
  Complete submission text file 0001600132-19-000147.txt   4311932

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20190930.xml EX-101.INS 804262
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20190930.xsd EX-101.SCH 34405
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20190930_cal.xml EX-101.CAL 48879
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20190930_def.xml EX-101.DEF 152836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20190930_lab.xml EX-101.LAB 477081
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20190930_pre.xml EX-101.PRE 265824
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 191195161
SIC: 2834 Pharmaceutical Preparations